AstraZeneca Expands China Presence with Over 30 Agreements at CIIE
At the 6th China International Import Expo (CIIE) in Shanghai, UK-based pharmaceutical giant AstraZeneca plc...
Greater Bay Area
Teva Partners with CR Guangdong to Launch Fremanezumab for Migraines in China’s GBA
Israel-based generics specialist Teva (NYSE: TEVA) has announced the initiation of a strategic partnership with...
Fosun Pharmaceutical to Acquire 14% Stake in UnitedHealthcare for USD 34 Million
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196) has announced plans to invest RMB 248.9...
Novartis’s Aimovig Approved by China’s NMPA for Preventive Migraines Treatment
Swiss pharmaceutical giant Novartis (NYSE: NVS) has announced that it has received market approval from...
Canton Biologics Secures Over RMB 300 Million in Series C Financing for Expansion
Canton Biologics Co., Ltd, a Guangzhou-based Contract Development and Manufacturing Organization (CDMO) specializing in biologic...
CDE’s 2022 Drug Review Report: A Year of Pandemic Response and Regulatory Milestones
The Center for Drug Evaluation (CDE) has released its comprehensive 2022 annual drug review report,...
AstraZeneca Restructures to Capture Opportunities in Guangdong-Hong Kong-Macao Greater Bay Area
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) is taking strategic steps to capitalize on the...
Jiahui Health and Gleneagles Hong Kong Hospital Partner for Integrated Healthcare Services
China-based Jiahui Health has entered into a strategic partnership with Gleneagles Hong Kong Hospital to...
China Unveils State Council Measures to Boost Foreign Direct Investment
The State Council of China has demonstrated its commitment to encouraging greater foreign investment by...
GeneMind Biosciences Secures RMB 400 Million in Series C Financing to Expand Gene Testing
Shenzhen-based DNA sequencer specialist, GeneMind Biosciences Co., Ltd, has reportedly raised RMB 400 million in...
Pingshan District and Fosun Pharma Ink Strategic Deal to Boost Biomedical Industry
The People’s Government of Pingshan District in Shenzhen has signed a cooperation framework agreement with...
Xiamen ITG Group and Fosun Health Collaborate on Big Health Industry Fund and Medical Device Commercialization
China-based Xiamen ITG Group Co., Ltd. (SHA: 600755) and Shanghai Fosun Health Technology (Group) Co.,...
Sinopharm Partners with Shenzhen to Boost High-End Medical Device and Pharmaceutical Innovation
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Shenzhen...
AstraZeneca Partners with Guangzhou Institute to Advance Respiratory Medicine Research
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) has announced a partnership with China’s Guangzhou Institute...
Sanofi Partners with Shenzhen’s Pingshan District to Boost Innovative Vaccines in China
French pharmaceutical major Sanofi (NASDAQ: SNY) has signed a partnership agreement with the Pingshan district...
AstraZeneca and HKSTP Expand Collaboration with MoU to Support Start-Ups
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) and Hong Kong Science and Technology Parks Corp....
YHLO Biotech Partners with NCRCID to Develop Advanced Tuberculosis Diagnostics
China-based Shenzhen YHLO Biotech Co., Ltd has entered into a strategic partnership with the National...
Shenzhen YHLO Biotech Partners with NCRCID for Advanced Tuberculosis Diagnostics
China-based Shenzhen YHLO Biotech Co., Ltd has announced a strategic partnership with the National Clinical...
Grand Pharmaceutical Group Reports 15.1% Revenue Growth in 2022 Financials
China-based Grand Pharmaceutical Group Limited (HKG: 0512) published its 2022 financials, reporting revenues of HKD...
HKUST and PhIRDA Sign MoU to Establish Innovation Centers
The Hong Kong University of Science and Technology (HKUST) and the China Pharmaceutical Innovation and...